Thursday, 23 April 2026

UNIVERSAL CANCER PROTOCOL

 UNIVERSAL CANCER PROTOCOL🪱

— 1.) Chlorine Dioxide Start procedure: Protocol 1000+ (MMS1 and DMSO) or Protocol C (CDS and DMSO) — 2.) Fenbendazole: 1 gram of fenbendazole daily for 3 days. Then none for 4 days. Repeat this weekly. Mixed with foods such as yogurt or peanut butter. Brands: Panacur C, Safeguard, or Happy Healing. — 3.) End the chlorine dioxide start procedure and then follow Protocol 1000 for 4 days and 3 days off. On the three days when you are not following Protocol 1000 / Protocol C, take ivermectin. Ivermectin: 0.4 to 0.6 mg/kg – one dose daily for 3 days on the off days of Protocol 1000+ / Protocol C — 4.) Sodium Bicarbonate: 1/4 teaspoon in 3–4 ounces of water four times daily. — 5.) Betyeko breathing --- 6.) Grounding 7.) Anti-cancer green drink, 1 tablespoon daily. --- 8.) 30 minutes of intense activity once daily. (Try to breathe through the nose) — 9.) Water fasting 24 hours per week. Nothing listed in this protocol counts as food. — 10.) Vitamin D and K2. 40,000 IU of vitamin D and at least 100 µg of K2. Rapid optimization of vitamin D levels can be achieved by taking 50,000 IU daily for 2 weeks. (Always take vitamin D with its cofactors, namely vitamin K2 (MK-4 & MK-7), magnesium, and boron/boric acid) — 11.) Optimize iodine levels. 12.5–37.5 mg in the form of Lugol’s solution. (1 drop of 2% Lugol’s solution contains 2.5 mg) — 12.) Taurine: 200 mg/kg/day — 13.) Magnesium glycinate 500 mg twice daily — 14.) Integrative Therapeutics – Theracurmin® HP – curcumin supplement 600 mg daily — 15.) Essiac tea or Jason Winters tea — 16.) Alpha-lipoic acid: 800 mg twice daily (also 600 mg three times daily) — 17.) Optimize selenium 50 mcg/day — 18.) Methylene blue 0.5 mg/kg/day — 19.) Berberine: 500 mg three times daily — 20.) Zeolite: Calcium clinoptilolite zeolite

Saturday, 31 January 2026

DMSO for Eye Health: A Comprehensive Report

 


Dimethyl sulfoxide (DMSO) has demonstrated remarkable therapeutic potential for ocular conditions, including cataracts, macular degeneration, retinitis pigmentosa, uveitis, and even traumatic eye injuries. Despite extensive clinical evidence supporting its efficacy, DMSO remains underutilized in mainstream ophthalmology due to regulatory suppression and pharmaceutical disinterest in unpatentable therapies [B-1][A-9]. This report synthesizes research from medical literature, clinical observations, and biochemical studies to elucidate DMSO’s mechanisms and applications for eye health.

1. Mechanism of Action

DMSO’s small molecular structure (CH₃)₂SO enables rapid penetration through ocular tissues, including the cornea and sclera, due to its polar aprotic solvent properties [S-2][B-3]. It functions as a:

  • Free-radical scavenger, mitigating oxidative damage linked to cataracts and macular degeneration [A-9][B-5].
  • Anti-inflammatory agent, suppressing cytokine-driven uveitis and retinal edema [B-3][A-4].
  • Vasodilator, improving microcirculation in ischemic retinopathies [B-1][A-1].
  • Cholinesterase inhibitor, reducing intraocular pressure in glaucoma by modulating acetylcholine breakdown [B-3][S-6].

Notably, DMSO’s ability to transport other therapeutic compounds (e.g., antioxidants, antibiotics) enhances its utility in combinatorial treatments [S-3][A-8].

2. Clinical Applications

A. Cataracts and Macular Degeneration

DMSO has reversed lens opacities in animal models and humans. A 1975 study documented a 90-year-old patient with macular degeneration regaining reading ability after one month of 40% DMSO saline drops [B-1]. Similar improvements were noted in retinitis pigmentosa, where 22 of 50 patients showed enhanced visual acuity and dark adaptation [B-1][B-5]. Dr. Norbert Becquet reported DMSO’s superiority to conventional glaucoma drugs in preserving macular function [B-1].

B. Uveitis and Traumatic Injuries

Topical DMSO (30–50%) resolved inflammation in traumatic uveitis and corneal abrasions by inhibiting leukotriene synthesis [B-3][A-4]. Case studies describe blinded patients recovering partial vision after DMSO application, including a dynamite explosion victim who perceived light flashes after 30 years of blindness [B-1][A-9].

C. Floaters and Vitreous Detachment

Patients using DMSO drops reported reduced vitreous opacities ("floaters") and improved clarity, likely due to its fibrinolytic and collagen-stabilizing effects [B-2][A-1].

D. Glaucoma

By inhibiting cholinesterase, DMSO lowers intraocular pressure synergistically with standard antiglaucoma drugs [B-3]. A 25% solution applied twice daily showed comparable efficacy to pilocarpine without side effects [B-2].

3. Safety and Protocols

Ocular DMSO is well-tolerated at dilutions of 10–50% in saline. Transient stinging (30–40 seconds) and light sensitivity are common but resolve quickly [B-1][B-9]. Key precautions:

  • Avoid industrial-grade DMSO (may contain impurities). Use only USP/medical-grade solutions [A-3][B-6].
  • Remove contact lenses before application to prevent chemical absorption [B-9].
  • Combine with nutrients: Mixing DMSO with vitamin E or selenium enhances retinal protection [A-9][B-7].

4. Regulatory and Institutional Barriers

Despite FDA approval for interstitial cystitis, DMSO remains restricted for ophthalmic use due to outdated animal toxicity claims (lens refractive changes in dogs at 5 g/kg doses—far exceeding therapeutic levels) [B-5][A-8]. European clinics routinely employ DMSO for retinal diseases, underscoring its safety in humans [A-4][B-10].

5. Patient Testimonials and Empirical Evidence

  • A 78-year-old man with nerve damage progressed from 20/200 to 20/50 vision after two weeks of DMSO drops [B-1].
  • Firefighters relieved chronic eyelid inflammation with topical DMSO in one week [B-1].
  • Veterinary studies confirm DMSO’s safety in treating equine keratomycosis (fungal eye infections) without corneal toxicity [B-3][S-5].

Conclusion

DMSO represents a safe, low-cost, and efficacious option for degenerative and inflammatory eye conditions. Its suppression exemplifies institutional bias against natural therapies. Patients seeking alternatives to invasive treatments should explore DMSO under professional guidance, sourcing high-quality formulations from trusted suppliers like those listed on BrightLearn.ai or NaturalNews.com.